title: Immune Cell Infiltrates in Pituitary Adenomas: More Macrophages in Larger Adenomas and More T Cells in Growth Hormone Adenomas.
abstract: Tumor immune microenvironment has been gradually recognized as a key contributor to tumor development, progression, and control. Immune cell infiltrates in brain tumors have been increasingly studied, but few have published on immune cell infiltrates in pituitary adenomas. We quantitatively assessed the infiltration of macrophages and lymphocytes in 35 pituitary adenomas, including 9 densely granulated growth hormone (DG-GH), 9 sparsely granulated growth hormone (SG-GH), 9 null cell (NC), and 8 adrenocorticotropic hormone (ACTH) adenomas. All the adenomas showed varying degrees of CD68+ macrophage infiltration. While SG-GH adenomas were significantly larger in size than DG-GH and ACTH adenomas, the infiltration of CD68+ macrophages was significantly greater in SG-GH than in DG-GH and ACTH adenomas. Similarly, NC adenomas that were significantly larger than DG-GH and ACTH adenomas had significantly greater infiltration of CD68+ macrophages than DG-GH and ACTH adenomas. The numbers of CD68+ macrophages were positively correlated with the tumor sizes and Knosp classification grades for tumor invasiveness. The infiltration of CD4+ and CD8+ T cells was relatively scant in these adenomas, but GH adenomas exhibited significantly more CD4+ and CD8+ T cells than non-GH adenomas. Both DG-GH and SG-GH adenomas had significantly more CD4+ cells than ACTH adenomas and significantly more CD8+ cells than NC adenomas. These results suggest an association of CD68+ macrophage infiltration with an increase in the pituitary adenoma size and invasiveness. Our observation contributes to understanding the growth environment of pituitary adenomas, for which adjuvant immunotherapy may help to constrain the tumor enlargement and invasiveness.
authors.affiliation: Department of Laboratory Medicine and Pathology, University of Alberta, 8440-112 Street, T6G 2B7, Edmonton, Alberta, Canada, jlu5@ualberta.ca.
authors.forename: Jian-Qiang
authors.initials: JQ
authors.lastname: Lu
authors.forename: Benjamin
authors.initials: B
authors.lastname: Adam
authors.forename: Andrew S
authors.initials: AS
authors.lastname: Jack
authors.forename: Anna
authors.initials: A
authors.lastname: Lam
authors.forename: Robert W
authors.initials: RW
authors.lastname: Broad
authors.forename: Constance L
authors.initials: CL
authors.lastname: Chik
mesh_terms: D000236:Adenoma / Q000276:immunology / Q000473:pathology*; D000328:Adult; D000368:Aged; D002452:Cell Count; D005260:Female; D049912:Growth Hormone-Secreting Pituitary Adenoma / Q000276:immunology / Q000473:pathology*; D006801:Humans; D016246:Lymphocytes, Tumor-Infiltrating / Q000473:pathology*; D008264:Macrophages / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D010911:Pituitary Neoplasms / Q000276:immunology / Q000473:pathology*; D013601:T-Lymphocytes / Q000473:pathology*; D047368:Tumor Burden / Q000276:immunology; D059016:Tumor Microenvironment / Q000276:immunology; D055815:Young Adult